Document is current
Any future updates will be listed below
-
Authors
Mulick, Amy R.
Henderson, Alasdair D.
Prieto-Merino, David
Mansfield, Kathryn E.
Matthewman, Julian
Quint, Jennifer K.
Lyons, Ronan A.
Sheikh, Aziz
McAllister, David A.
Nitsch, Dorothea
Langan, Sinéad M.
-
Funding
Funding for this research was provided by:
Wellcome Trust (205039/Z/16/Z)
Wellcome Trust (205039/Z/16/Z)
Innovative Medicines Initiative (821511)
Medical Research Council (MR/V005146/1)
- License Information
-
More Information
Article History
Received: 27 April 2022
Accepted: 13 December 2022
First Online: 18 December 2022
Competing interests
: AS is Director of the Asthma UK Centre for Applied Research and the HDR UK BREATHE Hub. KM declares consultancy fees from Amgen. DN is the UK Kidney Association Director of Informatics Research and is funded by the UK Kidney Association and Chiang Mai University, Thailand, and holds a grant from the Health Foundation, and past grants from GSK, unrelated to this work. JQ has received grants from The Health Foundation, MRC, GSK, Bayer, BI, British Lung Foundation, IQVIA, Chiesi AZ, Insmed and Asthma UK and personal fees for advisory board participation or speaking fees from GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca and Bayer. All other authors report no conflicts of interest.
